Methodological issues in estrogen treatment trials for Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 1052, Issue , 2005, Pages 173-181

  Mulnard, Ruth A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Clinical trial; Dementia; Design; Estrogen; Hormone

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; PLACEBO;

ALZHEIMER DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; DOSE RESPONSE; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; LOW DRUG DOSE; MINI MENTAL STATE EXAMINATION; TREATMENT OUTCOME;

EID: 25144452300     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1347.014     Document Type: Conference Paper

References (11)

1. FILLIT, H., H. WEINREB, I. CHOLST, et al. 1986. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 11: 337-345.
2. HONJO, H., Y. OGINO, K. NAITOH, et al. 1989. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). J. Steroid Biochem. Mol. Biol. 34: 521-525.
3. OHKURA, T., K. ISSE, K. AKAZAWA, et al. 1994. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr. J. 41: 361-371.
4. OHKURA, T., K. ISSE, K. AKAZAWA, et al. 1994. Low dose estrogen replacement therapy for Alzheimer disease in women. Menopause 1: 125-130.
5. HONJO, H., Y. OGINO & K. TANAKA. 1993. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled, double-blind study. J. Jpn. Menopause Soc. 1: 167-171.
6. HENDERSON, V.W., A. PAGANINI-HILL, B.L. MILLER, et al. 2000. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54: 295-301.
7. MULNARD, R.A., C.W. COTMAN, C. KAWAS, et al. 2000. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283: 1007-1015.
8. WANG, P.N., S.Q. LIAO, R.S. LIU, et al. 2000. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54: 2061-2066.
9. ASTHANA, S., S. CRAFT, L.D. BAKER, et al. 1999. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 24: 657-677.
10. ASTHANA, S., L.D. BAKER, E.Z. STANCZYK, et al. 2001. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 57: 605-612.
11. THAL, L.J., R.G. THOMAS, R.A. MULNARD, et al. 2003. Estrogen levels do not correlate with improvement in cognition. Arch. Neurol. 60: 209-212.